S&W Seed Company  

(Public, NASDAQ:SANW)   Watch this stock  
Find more results for SANW
8.90
-0.45 (-4.81%)
May 20 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.68 - 9.42
52 week 4.43 - 11.40
Open 9.28
Vol / Avg. 92,231.00/77,040.00
Mkt cap 82.53M
P/E     -
Div/yield     -
EPS -0.06
Shares 9.27M
Beta     -
Inst. own 51%
May 13, 2013
Q3 2013 S&W Seed Co Earnings Conference Call
Mar 18, 2013
S&W Seed Co at Roth Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin 1.07% 2.65%
Operating margin 1.95% 4.38%
EBITD margin - 6.31%
Return on average assets 1.60% 2.02%
Return on average equity 2.34% 2.16%
Employees 9 -
Carbon Disclosure Rating - -

Address

25552 South Butte Avenue
FIVE POINTS, CA 93624
United States - Map
+1-559-8842535 (Phone)
+1-302-5313150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

S&W Seed Company (S&W Seed) is engaged in breeding, contracting to grow, processing and selling agricultural commodities, which primarily include alfalfa seed and, to a lesser extent, wheat. Seed Holding, LLC and Stevia California, LLC are the Company�s wholly owned subsidiaries. As of January 29, 2010, Seed Holding, LLC owned 85% interest in S&W Seed. In January 2010, the Company acquired Seed Holding, LLC. In May 2010, the Company acquired S&W Seed Company, a general partnership. In July 2012, it acquired 640 acres of farmland in Calipatria, California, located in California's Imperial Valley. In August 2012, the Company purchased the rights to a portfolio of alfalfa varieties. In October 2012, the Company acquired Imperial Valley Seeds, Inc. In April 2013, it closed the acquisition of Seed Genetics International Pty Ltd.

Officers and directors

Mark S. Grewal President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Mark James Harvey Vice Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Matthew K. Szot Chief Financial Officer, Senior Vice President
Age: 38
Bio & Compensation  - Reuters
Daniel Z. Karsten Chief Operating Officer, Executive Vice President
Age: 45
Bio & Compensation  - Reuters
Dennis Jury Executive Vice President - Operations
Bio & Compensation  - Reuters
Fred Fabre Vice President - Sales and Marketing
Age: 60
Bio & Compensation  - Reuters
Danielson B. Gardner Vice President - Breeding and Genetics
Age: 46
Bio & Compensation  - Reuters
Grover T. Wickersham Non-Executive Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Michael M. Fleming Lead Independent Director
Age: 63
Bio & Compensation  - Reuters
Michael C. Culhane Independent Director
Age: 44
Bio & Compensation  - Reuters